Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;189(3):817-826.
doi: 10.1007/s10549-021-06335-z. Epub 2021 Aug 2.

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model

Affiliations

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model

Vinzenz Völkel et al. Breast Cancer Res Treat. 2021 Oct.

Abstract

Purpose: To extend the functionality of the existing INFLUENCE nomogram for locoregional recurrence (LRR) of breast cancer toward the prediction of secondary primary tumors (SP) and distant metastases (DM) using updated follow-up data and the best suitable statistical approaches.

Methods: Data on women diagnosed with non-metastatic invasive breast cancer were derived from the Netherlands Cancer Registry (n = 13,494). To provide flexible time-dependent individual risk predictions for LRR, SP, and DM, three statistical approaches were assessed; a Cox proportional hazard approach (COX), a parametric spline approach (PAR), and a random survival forest (RSF). These approaches were evaluated on their discrimination using the Area Under the Curve (AUC) statistic and on calibration using the Integrated Calibration Index (ICI). To correct for optimism, the performance measures were assessed by drawing 200 bootstrap samples.

Results: Age, tumor grade, pT, pN, multifocality, type of surgery, hormonal receptor status, HER2-status, and adjuvant therapy were included as predictors. While all three approaches showed adequate calibration, the RSF approach offers the best optimism-corrected 5-year AUC for LRR (0.75, 95%CI: 0.74-0.76) and SP (0.67, 95%CI: 0.65-0.68). For the prediction of DM, all three approaches showed equivalent discrimination (5-year AUC: 0.77-0.78), while COX seems to have an advantage concerning calibration (ICI < 0.01). Finally, an online calculator of INFLUENCE 2.0 was created.

Conclusions: INFLUENCE 2.0 is a flexible model to predict time-dependent individual risks of LRR, SP and DM at a 5-year scale; it can support clinical decision-making regarding personalized follow-up strategies for curatively treated non-metastatic breast cancer patients.

Keywords: Contralateral breast cancer; Follow-up; Mamma carcinoma; Metachronous metastasis; Recurrence; Risk prediction.

PubMed Disclaimer

Conflict of interest statement

Tom Hueting declares employment at Evidencio B.V. All other authors have no relevant conflict of interest to disclose.

Figures

Fig. 1
Fig. 1
a Area under the Receiver operating characteristic curve (AUC) per quarter year for the outcome locoregional recurrence (LRR). The lines are displayed with 95% Confidence Intervals. b Area under the Receiver operating characteristic curve (AUC) per quarter year for the outcome secondary primary (SP). The lines are displayed with 95% Confidence Intervals. c Area under the Receiver operating characteristic curve (AUC) per quarter year for the outcome distant metastasis (DM). The lines are displayed with 95% Confidence Intervals. Cox Cox proportional hazard model, PAR Parametric Spline Model, and RSF Random Survival Forest

References

    1. IKNL - integraal kankercentrum Nederland Cijfers over kanker: Incidentie, Aantal Borstkanker. https://iknl.nl
    1. Stewart BW, editor. World Cancer Report 2014. Lyon: IARC Press; 2014.
    1. Holleczek B, Arndt V, Stegmaier C, et al. Trends in breast cancer survival in Germany from 1976 to 2008–a period analysis by age and stage. Cancer Epidemiol. 2011;35:399–406. doi: 10.1016/j.canep.2011.01.008. - DOI - PubMed
    1. Hübner J, Katalinic A, Waldmann A, et al. Long-term incidence and mortality trends for breast cancer in Germany. Geburtshilfe Frauenheilkd. 2020;80:611–618. doi: 10.1055/a-1160-5569. - DOI - PMC - PubMed
    1. Yoshimura A, Ito H, Nishino Y, et al. Recent improvement in the long-term survival of breast cancer patients by age and stage in Japan. J Epidemiol. 2018;28:420–427. doi: 10.2188/jea.JE20170103. - DOI - PMC - PubMed